Portfolio Holdings Detail for ISIN IE00B3ZW0K18
Stock Name / Fund iShares S&P 500 EUR Hedged UCITS ETF (Acc)
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker IBCF(EUR) F
ETF Ticker IUES.AS(EUR) CXE
ETF Ticker IUSE.L(EUR) CXE
ETF Ticker IUSE.MI(EUR) CXE
ETF Ticker IUSEz(EUR) CXE
ETF Ticker IUSE(EUR) ETF Plus

Holdings detail for EW

Stock Name	Edwards Lifesciences Corp
Ticker	EW(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US28176E1082
LEI	YA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen: Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings: Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab: Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW): Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research: Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00: Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW): J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW): Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC: Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW): Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares S&P 500 EUR Hedged UCITS ETF (Acc) EW holdings

Date	Number of EW Shares Held	Base Market Value of EW Shares	Local Market Value of EW Shares	Change in EW Shares Held	Change in EW Base Value	Current Price per EW Share Held	Previous Price per EW Share Held
2025-09-30 (Tuesday)	91,509	USD 6,056,728	USD 6,056,728
2025-09-29 (Monday)	91,781	USD 6,039,706	USD 6,039,706	0	USD 54,159	USD 65.8056	USD 65.2155
2025-09-26 (Friday)	91,781	USD 5,985,547	USD 5,985,547	0	USD 69,086	USD 65.2155	USD 64.4628
2025-09-25 (Thursday)	91,781	USD 5,916,461	USD 5,916,461	0	USD 81,429	USD 64.4628	USD 63.5756
2025-09-24 (Wednesday)	91,781	USD 5,835,032	USD 5,835,032	0	USD 24,677	USD 63.5756	USD 63.3067
2025-09-18 (Thursday)	91,781	USD 5,810,355	USD 5,810,355	0	USD -14,060	USD 63.3067	USD 63.4599
2025-09-17 (Wednesday)	91,781	USD 5,824,415	USD 5,824,415	0	USD 9,502	USD 63.4599	USD 63.3564
2025-09-16 (Tuesday)	91,781	USD 5,814,913	USD 5,814,913	136	USD -112,628	USD 63.3564	USD 64.6794
2025-09-15 (Monday)	91,645	USD 5,927,541	USD 5,927,541	136	USD -125,459	USD 64.6794	USD 66.1465

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE00B3ZW0K18

Show aggregate share trades of EW

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-16 BUY 136 63.356* 66.51
2025-09-15 BUY 136 64.679* 66.52
2025-08-21 BUY 134 69.866* 66.49
2025-08-20 SELL -268 69.785* 66.47 Profit of 17,815 on sale
2025-08-13 BUY 268 66.283* 66.47
2025-08-12 BUY 134 65.986* 66.47
2025-08-08 SELL -134 67.219* 66.46 Profit of 8,906 on sale
2025-08-05 BUY 266 68.511* 66.45
2025-08-04 SELL -532 69.255* 66.43 Profit of 35,341 on sale
2025-08-01 SELL -134 68.657* 66.42 Profit of 8,900 on sale
2025-07-31 BUY 396 69.294* 66.40
2025-07-30 BUY 132 70.697* 66.38
2025-07-18 SELL -399 65.671* 66.39 Profit of 26,490 on sale
2025-07-16 SELL -266 65.658* 66.40 Profit of 17,662 on sale
2025-07-10 BUY 133 67.463* 66.39
2025-07-07 BUY 266 65.332* 66.40
2025-07-02 BUY 133 65.452* 66.42
2025-06-24 BUY 266 65.292* 66.44
2025-06-23 BUY 133 65.322* 66.45
2025-06-18 BUY 133 64.283* 66.49
2025-06-17 BUY 133 63.564* 66.51
2025-06-05 SELL -266 67.877* 66.53 Profit of 17,696 on sale
2025-06-03 BUY 266 68.220* 66.50
2025-05-28 BUY 1,474 67.829* 66.45
2025-05-27 BUY 402 67.205* 66.44
2025-05-22 SELL -134 66.312* 66.45 Profit of 8,904 on sale
2025-05-21 SELL -134 67.102* 66.44 Profit of 8,903 on sale
2025-05-20 SELL -268 69.069* 66.42 Profit of 17,801 on sale
2025-05-19 SELL -268 69.347* 66.40 Profit of 17,795 on sale
2025-05-15 BUY 134 68.723* 66.35
2025-05-14 BUY 268 68.444* 66.33
2025-05-13 BUY 402 67.637* 66.32
2025-05-12 BUY 804 67.315* 66.32
2025-05-09 BUY 402 65.386* 66.32
2025-05-02 BUY 134 66.541* 66.33
2025-04-30 BUY 5,804 66.409* 66.32
2025-04-28 BUY 125 66.386* 66.32
2025-04-25 SELL -125 66.887* 66.31 Profit of 8,289 on sale
2025-04-24 BUY 375 66.057* 66.32
2025-04-23 BUY 125 62.079* 66.35
2025-04-22 BUY 125 61.509* 66.40
2025-04-16 SELL -125 62.552* 66.57 Profit of 8,321 on sale
2025-04-15 BUY 125 62.465* 66.61
2025-04-14 BUY 250 61.465* 66.66
2025-04-11 BUY 250 61.207* 66.71
2025-04-10 BUY 125 61.053* 66.77
2025-04-09 BUY 125 63.324* 66.81
2025-04-08 BUY 250 61.470* 66.86
2025-04-07 SELL -125 63.172* 66.90 Profit of 8,363 on sale
2025-04-04 SELL -750 63.121* 66.94 Profit of 50,205 on sale
2025-04-01 SELL -250 66.482* 66.95 Profit of 16,738 on sale
2025-03-31 SELL -248 67.099* 66.95 Profit of 16,604 on sale
2025-03-28 SELL -248 65.518* 66.97 Profit of 16,608 on sale
2025-03-25 BUY 124 65.960* 67.00
2025-03-21 SELL -496 65.186* 67.03 Profit of 33,249 on sale
2025-03-20 SELL -372 65.410* 67.05 Profit of 24,944 on sale
2025-03-18 BUY 744 64.373* 67.11
2025-03-11 SELL -124 62.588* 67.36 Profit of 8,352 on sale
2025-03-10 SELL -372 63.234* 67.41 Profit of 25,077 on sale
2025-03-07 SELL -868 64.701* 67.45 Profit of 58,545 on sale
2025-03-05 SELL -372 67.679* 67.45 Profit of 25,090 on sale
2025-03-03 SELL -496 68.085* 67.43 Profit of 33,446 on sale
2025-02-27 SELL -124 68.568* 67.39 Profit of 8,357 on sale
2025-02-19 BUY 124 71.633* 67.16
2025-02-18 BUY 248 72.294* 67.08
2025-02-13 BUY 248 72.842* 66.80
2025-02-05 SELL -992 69.184* 66.52 Profit of 65,985 on sale
2025-02-04 BUY 124 68.715* 66.48
2025-01-29 BUY 124 68.263* 66.24
2025-01-28 BUY 125 69.605* 66.17
2025-01-24 BUY 375 65.592* 66.19
2025-01-23 BUY 875 66.295* 66.19
2025-01-22 BUY 625 66.260* 66.19
2025-01-21 BUY 125 67.276* 66.16
2025-01-16 BUY 744 67.822* 66.06
2025-01-15 BUY 124 68.197* 66.00
2025-01-10 BUY 124 71.633* 65.66
2024-12-10 BUY 124 69.865* 65.15
2024-12-09 BUY 496 66.937* 65.09
2024-12-05 SELL -248 68.501* 64.89 Profit of 16,093 on sale
2024-12-04 BUY 372 70.469* 64.70
2024-12-03 SELL -620 66.746* 64.63 Profit of 40,068 on sale
2024-12-02 BUY 248 67.367* 64.52
2024-11-29 SELL -5,762 67.554* 64.41 Profit of 371,114 on sale
2024-11-25 BUY 264 67.951* 63.72
2024-11-22 SELL -132 67.704* 63.53 Profit of 8,386 on sale
2024-11-21 SELL -132 66.958* 63.36 Profit of 8,364 on sale
2024-11-18 BUY 660 66.099* 62.87
2024-11-12 BUY 132 62.029* 62.92
2024-11-08 BUY 924 61.615* 63.03
2024-11-07 BUY 264 60.895* 63.20
2024-11-06 BUY 132 61.228* 63.36
2024-10-31 BUY 405 61.723* 64.27
2024-10-29 BUY 135 64.240* 64.46
2024-10-28 BUY 135 63.336* 64.69
2024-10-25 BUY 135 64.054* 64.85
2024-10-24 BUY 134 65.154* 64.74
2024-10-23 SELL -270 65.531* 64.35 Profit of 17,375 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-16	BUY	136	63.356*	66.51
2025-09-15	BUY	136	64.679*	66.52
2025-08-21	BUY	134	69.866*	66.49
2025-08-20	SELL	-268	69.785*	66.47 Profit of 17,815 on sale
2025-08-13	BUY	268	66.283*	66.47
2025-08-12	BUY	134	65.986*	66.47
2025-08-08	SELL	-134	67.219*	66.46 Profit of 8,906 on sale
2025-08-05	BUY	266	68.511*	66.45
2025-08-04	SELL	-532	69.255*	66.43 Profit of 35,341 on sale
2025-08-01	SELL	-134	68.657*	66.42 Profit of 8,900 on sale
2025-07-31	BUY	396	69.294*	66.40
2025-07-30	BUY	132	70.697*	66.38
2025-07-18	SELL	-399	65.671*	66.39 Profit of 26,490 on sale
2025-07-16	SELL	-266	65.658*	66.40 Profit of 17,662 on sale
2025-07-10	BUY	133	67.463*	66.39
2025-07-07	BUY	266	65.332*	66.40
2025-07-02	BUY	133	65.452*	66.42
2025-06-24	BUY	266	65.292*	66.44
2025-06-23	BUY	133	65.322*	66.45
2025-06-18	BUY	133	64.283*	66.49
2025-06-17	BUY	133	63.564*	66.51
2025-06-05	SELL	-266	67.877*	66.53 Profit of 17,696 on sale
2025-06-03	BUY	266	68.220*	66.50
2025-05-28	BUY	1,474	67.829*	66.45
2025-05-27	BUY	402	67.205*	66.44
2025-05-22	SELL	-134	66.312*	66.45 Profit of 8,904 on sale
2025-05-21	SELL	-134	67.102*	66.44 Profit of 8,903 on sale
2025-05-20	SELL	-268	69.069*	66.42 Profit of 17,801 on sale
2025-05-19	SELL	-268	69.347*	66.40 Profit of 17,795 on sale
2025-05-15	BUY	134	68.723*	66.35
2025-05-14	BUY	268	68.444*	66.33
2025-05-13	BUY	402	67.637*	66.32
2025-05-12	BUY	804	67.315*	66.32
2025-05-09	BUY	402	65.386*	66.32
2025-05-02	BUY	134	66.541*	66.33
2025-04-30	BUY	5,804	66.409*	66.32
2025-04-28	BUY	125	66.386*	66.32
2025-04-25	SELL	-125	66.887*	66.31 Profit of 8,289 on sale
2025-04-24	BUY	375	66.057*	66.32
2025-04-23	BUY	125	62.079*	66.35
2025-04-22	BUY	125	61.509*	66.40
2025-04-16	SELL	-125	62.552*	66.57 Profit of 8,321 on sale
2025-04-15	BUY	125	62.465*	66.61
2025-04-14	BUY	250	61.465*	66.66
2025-04-11	BUY	250	61.207*	66.71
2025-04-10	BUY	125	61.053*	66.77
2025-04-09	BUY	125	63.324*	66.81
2025-04-08	BUY	250	61.470*	66.86
2025-04-07	SELL	-125	63.172*	66.90 Profit of 8,363 on sale
2025-04-04	SELL	-750	63.121*	66.94 Profit of 50,205 on sale
2025-04-01	SELL	-250	66.482*	66.95 Profit of 16,738 on sale
2025-03-31	SELL	-248	67.099*	66.95 Profit of 16,604 on sale
2025-03-28	SELL	-248	65.518*	66.97 Profit of 16,608 on sale
2025-03-25	BUY	124	65.960*	67.00
2025-03-21	SELL	-496	65.186*	67.03 Profit of 33,249 on sale
2025-03-20	SELL	-372	65.410*	67.05 Profit of 24,944 on sale
2025-03-18	BUY	744	64.373*	67.11
2025-03-11	SELL	-124	62.588*	67.36 Profit of 8,352 on sale
2025-03-10	SELL	-372	63.234*	67.41 Profit of 25,077 on sale
2025-03-07	SELL	-868	64.701*	67.45 Profit of 58,545 on sale
2025-03-05	SELL	-372	67.679*	67.45 Profit of 25,090 on sale
2025-03-03	SELL	-496	68.085*	67.43 Profit of 33,446 on sale
2025-02-27	SELL	-124	68.568*	67.39 Profit of 8,357 on sale
2025-02-19	BUY	124	71.633*	67.16
2025-02-18	BUY	248	72.294*	67.08
2025-02-13	BUY	248	72.842*	66.80
2025-02-05	SELL	-992	69.184*	66.52 Profit of 65,985 on sale
2025-02-04	BUY	124	68.715*	66.48
2025-01-29	BUY	124	68.263*	66.24
2025-01-28	BUY	125	69.605*	66.17
2025-01-24	BUY	375	65.592*	66.19
2025-01-23	BUY	875	66.295*	66.19
2025-01-22	BUY	625	66.260*	66.19
2025-01-21	BUY	125	67.276*	66.16
2025-01-16	BUY	744	67.822*	66.06
2025-01-15	BUY	124	68.197*	66.00
2025-01-10	BUY	124	71.633*	65.66
2024-12-10	BUY	124	69.865*	65.15
2024-12-09	BUY	496	66.937*	65.09
2024-12-05	SELL	-248	68.501*	64.89 Profit of 16,093 on sale
2024-12-04	BUY	372	70.469*	64.70
2024-12-03	SELL	-620	66.746*	64.63 Profit of 40,068 on sale
2024-12-02	BUY	248	67.367*	64.52
2024-11-29	SELL	-5,762	67.554*	64.41 Profit of 371,114 on sale
2024-11-25	BUY	264	67.951*	63.72
2024-11-22	SELL	-132	67.704*	63.53 Profit of 8,386 on sale
2024-11-21	SELL	-132	66.958*	63.36 Profit of 8,364 on sale
2024-11-18	BUY	660	66.099*	62.87
2024-11-12	BUY	132	62.029*	62.92
2024-11-08	BUY	924	61.615*	63.03
2024-11-07	BUY	264	60.895*	63.20
2024-11-06	BUY	132	61.228*	63.36
2024-10-31	BUY	405	61.723*	64.27
2024-10-29	BUY	135	64.240*	64.46
2024-10-28	BUY	135	63.336*	64.69
2024-10-25	BUY	135	64.054*	64.85
2024-10-24	BUY	134	65.154*	64.74
2024-10-23	SELL	-270	65.531*	64.35 Profit of 17,375 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	406,402	0	1,881,727	21.6%
2025-09-18	684,520	1,177	3,487,981	19.6%
2025-09-17	484,322	210	1,603,065	30.2%
2025-09-16	811,953	856	2,055,937	39.5%
2025-09-15	611,012	104	1,391,882	43.9%
2025-09-12	982,928	1,100	2,234,227	44.0%
2025-09-11	514,234	828	1,919,009	26.8%
2025-09-10	669,705	149	1,567,941	42.7%
2025-09-09	441,493	0	925,375	47.7%
2025-09-08	632,587	672	1,251,939	50.5%
2025-09-05	334,037	300	934,006	35.8%
2025-09-04	380,318	0	871,931	43.6%
2025-09-03	701,943	459	1,170,966	59.9%
2025-09-02	397,396	53	1,208,872	32.9%
2025-08-29	397,628	800	844,318	47.1%
2025-08-28	604,087	4	1,056,653	57.2%
2025-08-27	493,608	822	875,886	56.4%
2025-08-26	480,268	0	868,213	55.3%
2025-08-25	796,556	0	1,181,258	67.4%
2025-08-22	552,739	1	1,011,678	54.6%
2025-08-21	873,044	798	1,597,742	54.6%
2025-08-20	847,847	38,699	1,560,105	54.3%
2025-08-19	613,349	33	1,256,577	48.8%
2025-08-18	668,719	439	1,642,759	40.7%
2025-08-15	369,455	513	826,723	44.7%
2025-08-14	514,202	6,112	864,593	59.5%
2025-08-13	567,857	299	1,347,264	42.1%
2025-08-12	547,773	12,316	1,428,277	38.4%
2025-08-11	487,823	0	1,152,630	42.3%
2025-08-08	661,697	20	1,224,458	54.0%
2025-08-07	669,931	982	1,297,469	51.6%
2025-08-06	880,028	413	1,551,659	56.7%
2025-08-05	661,933	8	1,592,649	41.6%
2025-08-04	572,165	268	1,310,044	43.7%
2025-08-01	678,028	5,600	1,308,863	51.8%
2025-07-31	831,401	249	1,817,975	45.7%
2025-07-30	1,305,016	693	2,481,808	52.6%
2025-07-29	1,129,154	58	2,399,223	47.1%
2025-07-28	684,101	2,111	2,276,892	30.0%
2025-07-25	1,669,752	920	6,616,259	25.2%
2025-07-24	455,593	0	2,607,898	17.5%
2025-07-23	444,645	0	1,978,110	22.5%
2025-07-22	447,883	511	2,702,925	16.6%
2025-07-21	568,293	27	1,249,727	45.5%
2025-07-18	590,448	59	2,118,402	27.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares S&P 500 EUR Hedged UCITS ETF (Acc)
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	IBCF(EUR) F
ETF Ticker	IUES.AS(EUR) CXE
ETF Ticker	IUSE.L(EUR) CXE
ETF Ticker	IUSE.MI(EUR) CXE
ETF Ticker	IUSEz(EUR) CXE
ETF Ticker	IUSE(EUR) ETF Plus